Pharmacists’ workplace safety during the COVID-19 pandemic
pdf

Keywords

pharmacy
pharmaceutical activity
security
workplace
COVID-19 pandemic

How to Cite

CHIHAI, S. and PISLA, M. (2023) “Pharmacists’ workplace safety during the COVID-19 pandemic”, One Health & Risk Management , 4(3), pp. 37-42. doi: 10.38045/ohrm.2023.3.06.

Abstract

Introduction. Pharmacists are likely to be exposed to lower risks in healthcare emergencies compared to health workers from other health sectors (primary care, emergency care or hospitals). This present research has assessed the risks of pharmaceutical workers during the COVID-19 pandemic, as well as analysed the safety measures applied within the workplace in order to present recommendations for the protection of pharmacists and reducing the risk factors.

Material and methods. A quantitative and a qualitative study was carried out during the present research. The quantitative study was carried out on a sample of 336 pharmacists and pharmacist assistants from different pharmacies. The qualitative study was based on in-depth interviews with 8 representatives from different areas of the pharmaceutical sector. 

Results.  The study results reflected several aspects regarding the roles of pharmacists, the risks they were subjected to, and the morbidity of pharmacists during the COVID-19 pandemic, as well as in terms of provision and maintaining safety workplace conditions.

Conclusions. Several recommendations were developed based on the analysis and conclusions of the research, which aimed at increasing the safety of pharmaceutical workers in public health emergencies such as epidemics or pandemics.

https://doi.org/10.38045/ohrm.2023.3.06
pdf

|Views: 278| |pdf Downloads: 156|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Svetlana CHIHAI, Mihail PISLA

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370